Literature DB >> 35484243

Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory.

Qing-Qing Li1, Jiang Chen1, Ping Hu2, Min Jia3, Jia-Hui Sun1,4, Hao-Yang Feng2, Feng-Chang Qiao2, Yan-Yu Zang1,4, Yong-Yun Shi5, Guiquan Chen1,4, Nengyin Sheng6, Yun Xu1,4, Jian-Jun Yang7, Zhengfeng Xu8, Yun Stone Shi9,10,11,12.   

Abstract

N-methyl-D-aspartic acid type glutamate receptors (NMDARs) play critical roles in synaptic transmission and plasticity, the dysregulation of which leads to cognitive defects. Here, we identified a rare variant in the NMDAR subunit GluN2A (K879R) in a patient with intellectual disability. The K879R mutation enhanced receptor expression on the cell surface by disrupting a KKK motif that we demonstrated to be an endoplasmic reticulum retention signal. Expression of GluN2A_K879R in mouse hippocampal CA1 neurons enhanced the excitatory postsynaptic currents mediated by GluN2A-NMDAR but suppressed those mediated by GluN2B-NMDAR and the AMPA receptor. GluN2A_K879R knock-in mice showed similar defects in synaptic transmission and exhibited impaired learning and memory. Furthermore, both LTP and LTD were severely impaired in the KI mice, likely explaining their learning and memory defects. Therefore, our study reveals a new mechanism by which elevated synaptic GluN2A-NMDAR impairs long-term synaptic plasticity as well as learning and memory.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35484243     DOI: 10.1038/s41380-022-01579-7

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  47 in total

Review 1.  The NMDA receptor complex as a therapeutic target in epilepsy: a review.

Authors:  Mehdi Ghasemi; Steven C Schachter
Journal:  Epilepsy Behav       Date:  2011-11-04       Impact factor: 2.937

Review 2.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 3.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.

Authors:  Pierre Paoletti; Camilla Bellone; Qiang Zhou
Journal:  Nat Rev Neurosci       Date:  2013-06       Impact factor: 34.870

4.  Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region.

Authors:  Constanze Reutlinger; Ingo Helbig; Barbara Gawelczyk; Jose Ignacio Martin Subero; Holger Tönnies; Hiltrud Muhle; Katrin Finsterwalder; Sascha Vermeer; Rolph Pfundt; Jürgen Sperner; Irina Stefanova; Gabriele Gillessen-Kaesbach; Sarah von Spiczak; Andreas van Baalen; Rainer Boor; Reiner Siebert; Ulrich Stephani; Almuth Caliebe
Journal:  Epilepsia       Date:  2010-09       Impact factor: 5.864

5.  An Epilepsy-Associated GRIN2A Rare Variant Disrupts CaMKIIα Phosphorylation of GluN2A and NMDA Receptor Trafficking.

Authors:  Marta Mota Vieira; Thien A Nguyen; Kunwei Wu; John D Badger; Brett M Collins; Victor Anggono; Wei Lu; Katherine W Roche
Journal:  Cell Rep       Date:  2020-09-01       Impact factor: 9.423

6.  GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction.

Authors:  Gaetan Lesca; Gabrielle Rudolf; Nadine Bruneau; Natalia Lozovaya; Audrey Labalme; Nadia Boutry-Kryza; Manal Salmi; Timur Tsintsadze; Laura Addis; Jacques Motte; Sukhvir Wright; Vera Tsintsadze; Anne Michel; Diane Doummar; Karine Lascelles; Lisa Strug; Patrick Waters; Julitta de Bellescize; Pascal Vrielynck; Anne de Saint Martin; Dorothee Ville; Philippe Ryvlin; Alexis Arzimanoglou; Edouard Hirsch; Angela Vincent; Deb Pal; Nail Burnashev; Damien Sanlaville; Pierre Szepetowski
Journal:  Nat Genet       Date:  2013-08-11       Impact factor: 38.330

7.  A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorder.

Authors:  Ana Fernández-Marmiesse; Hirofumi Kusumoto; Saray Rekarte; Iria Roca; Jin Zhang; Scott J Myers; Stephen F Traynelis; Mª Luz Couce; Luis Gutierrez-Solana; Hongjie Yuan
Journal:  Mov Disord       Date:  2018-04-11       Impact factor: 10.338

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

9.  Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.

Authors:  J Tarabeux; O Kebir; J Gauthier; F F Hamdan; L Xiong; A Piton; D Spiegelman; É Henrion; B Millet; F Fathalli; R Joober; J L Rapoport; L E DeLisi; É Fombonne; L Mottron; N Forget-Dubois; M Boivin; J L Michaud; P Drapeau; R G Lafrenière; G A Rouleau; M-O Krebs
Journal:  Transl Psychiatry       Date:  2011-11-15       Impact factor: 6.222

10.  GRIN2A mutations cause epilepsy-aphasia spectrum disorders.

Authors:  Gemma L Carvill; Brigid M Regan; Simone C Yendle; Brian J O'Roak; Natalia Lozovaya; Nadine Bruneau; Nail Burnashev; Adiba Khan; Joseph Cook; Eileen Geraghty; Lynette G Sadleir; Samantha J Turner; Meng-Han Tsai; Richard Webster; Robert Ouvrier; John A Damiano; Samuel F Berkovic; Jay Shendure; Michael S Hildebrand; Pierre Szepetowski; Ingrid E Scheffer; Heather C Mefford
Journal:  Nat Genet       Date:  2013-08-11       Impact factor: 38.330

View more
  1 in total

Review 1.  NMDA Receptor C-Terminal Domain Signalling in Development, Maturity, and Disease.

Authors:  Kirsty Haddow; Peter C Kind; Giles E Hardingham
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.